摘要：

Questions of Oncology, 2000; 46(2):199. 25. Mepolizumab for severe eosinophilic asthma (DREAM):a multicentre, donble-blind, placebo-controlled trial. The Lancet, 2012; 308:651-659. A phaseII placebo-controlled study of tralokinumab in moderate –to-severe asthma. Eur.

展开